These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Expression and inducibility of antigens in severe combined immunodeficient mice recognized by human anti-P450 antibodies. Rajasenan RS; Riley RJ; Leeder JS Toxicol Appl Pharmacol; 1995 Nov; 135(1):89-99. PubMed ID: 7482543 [TBL] [Abstract][Full Text] [Related]
4. Catalytic role of cytochrome P4502B6 in the N-demethylation of S-mephenytoin. Heyn H; White RB; Stevens JC Drug Metab Dispos; 1996 Sep; 24(9):948-54. PubMed ID: 8886603 [TBL] [Abstract][Full Text] [Related]
5. Autoantibodies against cytochrome P450s in sera of children treated with immunosuppressive drugs. Lytton SD; Berg U; Nemeth A; Ingelman-Sundberg M Clin Exp Immunol; 2002 Feb; 127(2):293-302. PubMed ID: 11876753 [TBL] [Abstract][Full Text] [Related]
6. Autoantibodies against cytochromes P-4502E1 and P-4503A in alcoholics. Lytton SD; Helander A; Zhang-Gouillon ZQ; Stokkeland K; Bordone R; Aricò S; Albano E; French SW; Ingelman-Sundberg M Mol Pharmacol; 1999 Feb; 55(2):223-33. PubMed ID: 9927612 [TBL] [Abstract][Full Text] [Related]
7. Human liver microsomes are efficient catalysts of 1,3-butadiene oxidation: evidence for major roles by cytochromes P450 2A6 and 2E1. Duescher RJ; Elfarra AA Arch Biochem Biophys; 1994 Jun; 311(2):342-9. PubMed ID: 8203896 [TBL] [Abstract][Full Text] [Related]
8. Epitope mapping studies with human anti-cytochrome P450 3A antibodies. Leeder JS; Gaedigk A; Lu X; Cook VA Mol Pharmacol; 1996 Feb; 49(2):234-43. PubMed ID: 8632755 [TBL] [Abstract][Full Text] [Related]
9. Regulation of two members of the steroid-inducible cytochrome P450 subfamily (3A) in rats. Cooper KO; Reik LM; Jayyosi Z; Bandiera S; Kelley M; Ryan DE; Daniel R; McCluskey SA; Levin W; Thomas PE Arch Biochem Biophys; 1993 Mar; 301(2):345-54. PubMed ID: 7681660 [TBL] [Abstract][Full Text] [Related]
10. Induction of liver microsomal cytochrome P450 in cynomolgus monkeys. Bullock P; Pearce R; Draper A; Podval J; Bracken W; Veltman J; Thomas P; Parkinson A Drug Metab Dispos; 1995 Jul; 23(7):736-48. PubMed ID: 7587963 [TBL] [Abstract][Full Text] [Related]
11. Kinetic analysis of the activation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by heterologously expressed human P450 enzymes and the effect of P450-specific chemical inhibitors on this activation in human liver microsomes. Patten CJ; Smith TJ; Murphy SE; Wang MH; Lee J; Tynes RE; Koch P; Yang CS Arch Biochem Biophys; 1996 Sep; 333(1):127-38. PubMed ID: 8806763 [TBL] [Abstract][Full Text] [Related]
12. Role of a potent inhibitory monoclonal antibody to cytochrome P-450 3A4 in assessment of human drug metabolism. Mei Q; Tang C; Assang C; Lin Y; Slaughter D; Rodrigues AD; Baillie TA; Rushmore TH; Shou M J Pharmacol Exp Ther; 1999 Nov; 291(2):749-59. PubMed ID: 10525096 [TBL] [Abstract][Full Text] [Related]
13. Differential selectivity in carbamazepine-induced inactivation of cytochrome P450 enzymes in rat and human liver. Masubuchi Y; Nakano T; Ose A; Horie T Arch Toxicol; 2001 Nov; 75(9):538-43. PubMed ID: 11760814 [TBL] [Abstract][Full Text] [Related]
14. Anti-liver endoplasmic reticulum autoantibodies are directed against human cytochrome P-450IA2. A specific marker of dihydralazine-induced hepatitis. Bourdi M; Larrey D; Nataf J; Bernuau J; Pessayre D; Iwasaki M; Guengerich FP; Beaune PH J Clin Invest; 1990 Jun; 85(6):1967-73. PubMed ID: 2347920 [TBL] [Abstract][Full Text] [Related]
15. Metabolism of theophylline by cDNA-expressed human cytochromes P-450. Ha HR; Chen J; Freiburghaus AU; Follath F Br J Clin Pharmacol; 1995 Mar; 39(3):321-6. PubMed ID: 7619675 [TBL] [Abstract][Full Text] [Related]
16. Role of human cytochrome P450 3A4 in metabolism of medroxyprogesterone acetate. Kobayashi K; Mimura N; Fujii H; Minami H; Sasaki Y; Shimada N; Chiba K Clin Cancer Res; 2000 Aug; 6(8):3297-303. PubMed ID: 10955816 [TBL] [Abstract][Full Text] [Related]
17. Biotransformation of parathion in human liver: participation of CYP3A4 and its inactivation during microsomal parathion oxidation. Butler AM; Murray M J Pharmacol Exp Ther; 1997 Feb; 280(2):966-73. PubMed ID: 9023313 [TBL] [Abstract][Full Text] [Related]
18. Evidence for cytochrome P450 2A6 and 3A4 as major catalysts for N'-nitrosonornicotine alpha-hydroxylation by human liver microsomes. Patten CJ; Smith TJ; Friesen MJ; Tynes RE; Yang CS; Murphy SE Carcinogenesis; 1997 Aug; 18(8):1623-30. PubMed ID: 9276639 [TBL] [Abstract][Full Text] [Related]
19. Human reductive halothane metabolism in vitro is catalyzed by cytochrome P450 2A6 and 3A4. Spracklin DK; Thummel KE; Kharasch ED Drug Metab Dispos; 1996 Sep; 24(9):976-83. PubMed ID: 8886607 [TBL] [Abstract][Full Text] [Related]
20. Induction of the male-specific cytochrome P450 3A2 in female rats by phenytoin. Ghosal A; Sadrieh N; Reik L; Levin W; Thomas PE Arch Biochem Biophys; 1996 Aug; 332(1):153-62. PubMed ID: 8806720 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]